AINeutralGoogle DeepMind Blog · May 166/10
🧠
Uncovering repurposed medicines to fight liver fibrosis
Stanford researchers are leveraging AI tools called Co-Scientist to accelerate drug discovery for liver fibrosis treatment by identifying existing medicines that could be repurposed for this chronic liver disease. This approach demonstrates how artificial intelligence can streamline the pharmaceutical research process and potentially bring therapies to market faster.
